Local/regional failure in patients with rhabdomyosarcoma (rms) and microscopic residual disease
L.M. Smith(University of Utah), Sarah S. Donaldson(Stanford University), Fran Laurie(University of Massachusetts Chan Medical School), J.M. Michalski(Washington University in St. Louis), Moody D. Wharam(Johns Hopkins University), J R Anderson(St James's University Hospital), John C. Breneman(University of Cincinnati)
International Journal of Radiation Oncology*Biology*Physics
November 1, 2001
Cited by 0
Related Papers
Proton FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases
|JAMA Oncology|2022|557
Long-Term Outcomes Among Adult Survivors of Childhood Central Nervous System Malignancies in the Childhood Cancer Survivor Study
|JNCI Journal of the National Cancer Institute|2009|530
A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases
|International Journal of Radiation Oncology*Biology*Physics|2002|508
The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: A report from the childhood cancer survivor study
|Pediatric Blood & Cancer|2013|459
Medical Care in Long-Term Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study
|Journal of Clinical Oncology|2008|418